Bergen Brunswig Is Planning Securities Sale
ORANGE — Bergen Brunswig Corp. said it filed plans with regulators to sell up to $400 million worth of securities. The drug supplier intends to sell debt securities, preferred stock, common stock or warrants to purchase stock from time to time. Proceeds will be used for general corporate purposes, including repayment of debt, possible acquisitions or working capital needs.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
